-
Sector Analysis
NewAsia-Pacific (APAC) Sport Technology Sponsorship Landscape – Analysing Biggest Deals, Sports League, Brands and Case Studies
APAC Sport Technology Sponsorship Landscape Report Overview The annual deal value in the APAC sports technology sponsorship market was $3.63 million in 2024. Technology companies are joining forces with prominent athletic events and organizations. They are doing this to showcase their latest innovations. Technology is always developing and growing. From fan apps to virtual reality, technology has permeated every facet of sports technology. The APAC sport technology sponsorship report provides an overview of the sector across the APAC region. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IL2-CD25 in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IL2-CD25 in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IL2-CD25 in Systemic Lupus Erythematosus Drug Details: BMS-986326 (IL-2/CD25) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IL2-CD25 in Subacute Cutaneous Lupus Erythematosus (SCLE)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IL2-CD25 in Subacute Cutaneous Lupus Erythematosus (SCLE) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IL2-CD25 in Subacute Cutaneous Lupus Erythematosus (SCLE) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IL2-CD25 in Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IL2-CD25 in Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IL2-CD25 in Chronic Cutaneous...
-
Sector Analysis
NewCell and Gene Therapies in Ophthalmology – Disease Overview, Treatment Options and Future Market Assessment
Cell and Gene Therapies in Ophthalmology Market Report Overview The Cell and Gene Therapies (CGT) in ophthalmology market was $46 million in 2023. The market will experience moderate growth during the forecast period with gene therapies targeting Leber congenital amaurosis (LCA) and retinitis likely to be the primary drivers of the CGT market in the ophthalmology space. The CGT in ophthalmology market research report will aid clients in gaining insight into the competitive landscape of leading CGT agents in ophthalmology...
-
Product Insights
NewPulse Oximeter Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Pulse Oximeter Systems Pipeline Market Report Overview A pulse oximeter system is a photoelectric instrument that noninvasively and continuously measures the oxygen saturation of blood. A pulse oximeter consists of the monitor containing the batteries and display, and the probe that senses the pulse. The pulse oximeter systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the...
-
Sector Analysis
NewCell and Gene Therapies in CNS Disorders – Disease Overview, Treatment Options and Future Market Assessment
Reasons to buy the ‘Cell and Gene Therapies in CNS Disorders’ report: The report covers the global scope of drug development focusing mainly on the 8MM including the US, 5EU, Japan, and South Korea. The report focuses on the marketed CGT assets addressing CNS disorders as well as the top five CNS disorders with the most CGT pipeline assets. The report throws light on the competitive landscape of leading CGT agents in CNS Disorders including launch date projections, analyst consensus...
-
Product Insights
NewElectrophysiology Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Electrophysiology Ablation Catheters Pipeline Market Report Overview Electrophysiology ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. The electrophysiology ablation catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and...
-
Sector Analysis
Spinal Fusion Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Spinal Fusion Market Report Overview Spinal Fusion market size was valued at $9.27 billion in 2023 and is forecast to grow at a CAGR of more than 1% during 2023 and 2033. Factors such as the advancement in navigation and imaging technologies will drive the market growth. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. The spine is made...
-
Sector Analysis
Surgical Stapling Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Surgical Stapling Devices Market Report Overview The Surgical Stapling Devices market size was valued at $4.09 billion in 2023. The market is expected to grow at a CAGR of more than 7% during 2023-2033. A Surgical Stapling Device is a medical device that is used to join tissues by implanting staples after surgery and which accelerates the healing. Surgical Stapling Devices Market Outlook 2023-2023 ($ Billion) Buy The Full Report for More Insights on The Surgical Stapling Devices Market Forecast...